Tampa, Fla.-based Moffitt Cancer Center recorded operating income of $238.4 million (6.9% operating margin) for fiscal year 2026, up from operating income of $127.5 million (4.2% margin) in fiscal 2025, according to its financial report for the 12 months ended June 30.
Moffitt reported total revenue of $3.4 billion in fiscal 2026, a 14.3% increase year over year. Patient service revenue rose 14% to $3 billion. Other revenue, which includes state appropriations and grants, increased 14% to $345 million.
Total expenses were $3.2 billion for fiscal 2026, an 11.1% increase year over year. Salaries, wages, benefits and faculty fees totaled $1.5 billion, a 12.7% increase. Supplies rose 8.1% to $1.2 billion. Purchased services increased 21% to $276 million.
Moffitt posted net income of $362.8 million in fiscal 2026, up from $216.6 million the prior year, aided by a 38.8% increase in nonoperating gains to $125.9 million.
The post Moffitt Cancer Center’s operating margin climbs to 6.9% in FY 2026 appeared first on Becker's Hospital Review | Healthcare News & Analysis.